In murine allo-HCT models, exogenous type I IFN administration augments CTL responses through the increased sensitivity of host target tissues and leukemia to respond to cell mediated cytotoxicity in CD8-dependent GVHD/GVT model regardless of decreasing GVHD response in CD4-dependent model (158). Here, CD8A is linked to graft versus host disease.